M-Pharma
0678.937.543 · rovalta.com · 09/11/2026
ACTIVE
M-Pharma
Financial year 2025 · Closed on 28/12/2025
Net result-11,1 k €+95,8 %over 1 year
Gross margin-5,1 k €+96,4 %over 1 year
Equity-242,8 k €-4,8 %over 1 year
Overview
Identity
Source · BCE/KBOM-Pharma is a Private limited company incorporated in 2017. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0678.937.543
- Incorporation
- 27/07/2017
- Legal form
- Private limited company
- Registered office
- Borsbeeksebrug 30
2600 Antwerpen · FlandreSee on map - Contributed capital
- 768 600,00 €
- Latest accounts
- 28/12/2025
Activities (NACE)
Signals
Healthy social debts
Financials
Source · NBB, 9 filingsTrend over 8 financial years
| 2025 | 2024 | 2023 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -5,1 k € | +96.4% | -142 k € | -221% | -44,2 k € | +45.1% | -80,6 k € | +5.3% | -85,1 k € |
| EBITDA | -5,7 k € | +97.9% | -269,9 k € | -133% | -115,9 k € | +17.6% | -140,7 k € | -3.4% | -136,1 k € |
| Operating result | -10,7 k € | +96.1% | -269,9 k € | -133% | -115,9 k € | +20.3% | -145,5 k € | -0.8% | -144,4 k € |
| Net result | -11,1 k € | +95.8% | -264,6 k € | -150% | -105,9 k € | +20.9% | -133,9 k € | +5.3% | -141,4 k € |
| Balance sheet | |||||||||
| Equity | -242,8 k € | -4.8% | -231,7 k € | -804% | 32,9 k € | -76.3% | 138,9 k € | -49.1% | 272,7 k € |
| Total assets | 5,9 k € | -62.5% | 15,9 k € | -69.3% | 51,8 k € | -73.8% | 197,5 k € | -35.8% | 307,9 k € |
| Cash | 3,5 k € | +212% | 1,1 k € | -71.7% | 4 k € | -17.5% | 4,8 k € | -13.7% | 5,6 k € |
| Debts | 243,8 k € | -1.5% | 247,6 k € | +1213% | 18,9 k € | -67.9% | 58,7 k € | +66.9% | 35,2 k € |
| Other | |||||||||
| Workforce | – | – | 0,9 ETP | – | – | ||||
Board of directors
Source · NBB, accounts to 28/12/20253 active · 4 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
AALBERTUS VAN DE WEERD | Managersince 01/10/2019 | ||
ERIK HEUTHORST | Managersince 01/10/2019 | ||
HUBERTUS VERHOEF | Managersince 01/10/2019 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Aalbertus Gijsbert Rik Van De Weerd | Director2024 accountsManager2020 accounts | ||
Erik August Heuthorst | Director2024 accountsManager2020 accounts |
Other companies at this address
Borsbeeksebrug 30 2600 Antwerpen| Company | CBE no. |
|---|---|
ABel Trust● Active | 1043.406.432 |
ChipSoft België● Active | 0812.016.890 |
KRUIDVAT● Active | 0446.891.668 |
Kuehne + Nagel● Active | 0404.531.966 |
Kuehne + Nagel Fulfillment● Active | 0455.958.002 |
LOGISTICS KONTICH● Active | 0874.061.852 |
NACORA INSURANCE BROKERS● Active | 0457.398.649 |
Teleperformance Belgium● Active | 0773.614.491 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2023 | 2022 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Micro model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 30/12/2024 | 01/01/2024 | 02/01/2023 | 03/01/2022 | 28/12/2020 | 01/01/2020 |
| Closing of the financial year | 28/12/2025 | 31/12/2024 | 31/12/2023 | 01/01/2023 | 02/01/2022 | 27/12/2020 |
| Length of the financial year | 13 months | 12 months | 12 months | 13 months | 14 months | 12 months |
| Filing date | 09/10/2026 | 22/09/2025 | 26/08/2024 | 22/08/2023 | 08/08/2022 | 20/08/2021 |
| General meeting | 09/10/2026 | 25/06/2025 | 28/06/2024 | 25/06/2023 | 25/06/2022 | 25/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 28/12/2025 | 09/10/2026 | 09/10/2026 | Dutch | |
| Micro model | 31/12/2024 | 25/06/2025 | 22/09/2025 | Dutch | |
| Abridged model | 31/12/2023 | 28/06/2024 | 26/08/2024 | Dutch | |
| Abridged model | 01/01/2023 | 25/06/2023 | 22/08/2023 | Dutch | |
| Abridged model | 02/01/2022 | 25/06/2022 | 08/08/2022 | Dutch | |
| Abridged model | 27/12/2020 | 25/06/2021 | 20/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 26/06/2020 | 21/08/2020 | Dutch | |
| Abridged modelCorrection | 31/12/2018 | 27/06/2019 | 24/09/2019 | Dutch | |
| Abridged model | 31/12/2018 | 27/06/2019 | 29/08/2019 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 28/12/20253 active · 4 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
AALBERTUS VAN DE WEERD | Managersince 01/10/2019 | ||
ERIK HEUTHORST | Managersince 01/10/2019 | ||
HUBERTUS VERHOEF | Managersince 01/10/2019 |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Aalbertus Gijsbert Rik Van De Weerd | Director2024 accountsManager2020 accounts | ||
Erik August Heuthorst | Director2024 accountsManager2020 accounts |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates03/01/2025Benoeming en ontslag van een bestuurder
- Other04/02/2022WIJZIGING VAN HET BOEKJAAR
- Other06/01/2022BOEKJAAR
- Other19/01/2021STATUTEN (VERTALING, COORDINATIE, OVERIGE
- Mandates29/10/2019Benoeming en ontslag zaakvoerder
- Other31/07/2017Uit een akte verleden voor notaris Heleen Deconinck te Erpe-Mere op 27 juli 2017, blijkt dat volgende
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings8 filings
Mandates
ERIK HEUTHORST
AALBERTUS VAN DE WEERD
HUBERTUS VERHOEF
M-Pharma
Aalbertus Gijsbert Rik Van De Weerd
Hubertus Cornelus Verhoef
Erik August Heuthorst
2017201820192020202120222023202420252026
M-Pharma
Borsbeeksebrug 30, 2600 Berchem (Antwerp)Prinses Clementinalaan 16, 9000 Gent
Manager
Manager
Manager
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Borsbeeksebrug 30, 2600 Berchem (Antwerp)Current | accounts 2024 → 2025 | Accounts 2025 · 2026-00557235 |
| Prinses Clementinalaan 16, 9000 Gent | accounts 2022 → 2023 | Accounts 2023 · 2024-00373078 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| M-PharmaCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00557235 |
Events
- 2025Annual accounts 2025-11,1 k €↑
- 2024Annual accounts 2024-264,6 k €↓
- 2023Annual accounts 2023-105,9 k €↑
- 2023Annual accounts 2023-133,9 k €↑
- 2022Annual accounts 2022-141,4 k €↑
- 2020Annual accounts 2020-175 k €↓
- 2019Annual accounts 2019-77,8 k €↑
- 2018Annual accounts 2018-101,6 k €
- 27/07/2017IncorporationPrivate limited company